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S u m m a r y
Systemic sclerosis is an autoim m une connective tissue disease characterized by vascular 
abnorm alities and fibrotic changes in skin and in ternal organs. The aim of the study was to 
investigate involvement of the central nervous system  in systemic sclerosis and the value 
of computed tomography (CT) and magnetic resonance imaging (MRI) in evaluation of central 
nervous system involvement in systemic sclerosis.
26 patients with neuropsychiatric symptoms in the course of systemic sclerosis were investigated 
for central nervous system abnormalities by computed tomography (CT) and magnetic resonance 
imaging (MRI).
Among these 26 symptomatic patients lesions in brain MRI and CT examinations were present 
in 54% and in 50% patients respectively. Most common findings (in 46% of all patients), were 
symptoms of cortical and subcortical atrophy, seen in both, MRI and CT. Single and multiple focal 
lesions, predominantly in the white matter, were detected by MRI significantly more frequently as 
compared to CT (62% and 15% patients respectively).
Presence of brain atrophy and focal lesions in CT and MR correlated with disease duration (both 
p<0,0001), extent of skin involvement (p<0,01) and presence of pulmonary fibrosis in the course of 
the systemic sclerosis (p=0.001).
These data indicate that brain involvement is common in patients with severe systemic sclerosis. 
MRI show s significantly higher than  CT sensitiv ity  in detection focal b rain  lesions in these 
patients.
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Background
Systemic sclerosis (SSc) is a chronic connective tissue disease 
of autoimmune etiology, characterized by progressive fibrosis 
and vascular abnormalities in the skin, subcutaneous tissue 
and internal organs, such as lung, heart, gastro-intestinal 
tract and kidneys [1]. Nearly all patients with systemic scle-
rosis are affected by episodic vasospasm within distal extre-
mities (Raynaud phenomenon). Repeated attacks of Raynaud 
phenomenon may contribute to vascular abnormalities in 
systemic sclerosis by a mechanism of reperfusion injury of 
the endothelium [2]. Several data indicate that the pheno-
menon is not restricted to extremities. It can also occur in 
internal organs, such as lung and heart [3]. Generalized vaso-
spastic tendency and vasculopathy might also have an effect 
on the central nervous system [4].
However, till now only a limited number of studies, have 
addressed the issue of central nervous system involvement 
in SSc [5, 6, 7, 8]. Impaired cerebral blood flow was shown 
by Cutolo et al. [9]. Cases of cerebritis [10] and intracerebral 
hemorrhage [11, 12] and mental disorders [13] were repor-
ted in a few papers in patients with SSc. Clinical neuropsy-
chiatric symptoms are relatively rare in SSc. These include 
headaches, vertigo, loss of consciousness, hypo-/dysmnesia, 
depressive, mild cognitive impairment and organic brain 
damage syndromes, transient ischaemic attacks (TIA) and 
cerebral infarction with paresis [14].
Brain lesions can be detected with contemporary imaging 
techniques, including computed tomography (CT), magne-
tic resonance (MRI) and single photon emission computed 
tomography (SPECT) [15 ,16, 17, 18]. 
The aim of this study was to investigate the frequency of 
brain abnormalities in SSc and to assess the value of com-
puted tomography and magnetic resonance imaging in eva-
luation of central nervous system involvement in systemic 
sclerosis. 
Materials and methods
Patients. 26 patients with neuropsychiatric symptoms in 
the course of SSc, aged 27–72, were enrolled into the study. 
All patients met the American College of Rheumatology cri-
teria for the diagnosis of SSc: 17 patients were affected by 
the diffuse cutaneous variant (dSSc) and 9 by the limited 
cutaneous variant (lSSc) of the disease. The group (tab. 1.) 
included 25 females and 1 male. Mean age was 50 years 
(range 27–72, SD 12 years). Mean disease duration was 10 
years in the observed group of patients (11 years in lSSc 
subset and 9 years in dSSc subset). The control group inclu-
ded 26 age- and sex-matched healthy volunteers. Patients 
with other than SSc risk factors of vascular brain disease 
(hypertension or diabetes) were excluded from the study. 
No abnormal CT findings were obtained in the control 
group. MRI technique (FLAIR sequence) revealed wide-
ning Virchow-Robin spaces in 3 patients (aged range 50–60 
years). 
Clinical evaluation. Complete clinical evaluations inclu-
ding accurate assessment of neurologic condition were 
performed in all SSc patients. In particular, cutaneous 
involvement was scored according to Rodnan. The presen-
ce of Raynaud phenomenon was examined in all patients. 
A variety of tests were utilised to evaluate internal organ 
involvement: cine esophagraphy and/or eosophagus scyn-
tygraphy, gastroscopy, colonoscopy, chest X-ray,  pulmonary 
function tests, HRCT of lungs, electrocardiography and 
echocardiography. Basic laboratory tests and serological 
screening for antinuclear antibodies, anticardiolipin antibo-
dies and lupus anticoagulant antibodies (IgG and IgM clas-
ses) were performed with the use of enzme linked immuno-
sorbent assay.
CT and MRI. In all patients brain CT and MRI examina-
tions were performed. CT examinations consisted of 3mm 
slices for posterior fossa and 7mm for the rest of the brain. 
No contrast media was administered. MRI examinations 
 consisted of SE and FSE sequences, T1-, T2-weighted and 
FLAIR images of 5mm slices with 0,5mm gap. In 5 cases 
DWI were performed for the exclusion of early stroke. In 
3 cases paramagnetic i.v. contrast media was administered 
(0,2ml/kg).
Statistical analysis. In order to compare clinical,  laboratory 
and imaging findings, the obtained data were stratified 
by the presence or absence of certain clinical features 
Table 1.  Main clinical data of patients in the studied group.
Tabela 1. Charakterystyka kliniczna pacjentów w grupie badanej.
lSSc(n=9) dSSc(n = 17)
Mean age (yrs)(range; SD) 49 (32–61; 12,8) 50 (27–72; 12)
Females/males ratio 9/0 16/1
Mean disease duration (yrs) (range; SD) 11 (4–26; 7,2) 9 (1–23; 6,3)
Rodnan skin score (mean value, range; SD) 12,5 (1–22; 7,8) 17 (1–22; 6,3)
(yrs) (mean value, range; SD) 15 (4–26; 7,2) 10 (1–23; 6,3)
Onset of skin sclerosis (yrs) (mean value, range; SD) 11 (1–22; 7,8) 9 (1–22; 6,3)
Interval between the onset of Raynaud’s phenomenon 
and skin sclerosis(yrs) (mean value, range; SD) 8 (1–18; 6,8) 4 (0–20; 6,5)
Skin sclerosis 100% 100%
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( neuropsychiatric, cardiac, pulmonary, renal, gastric and 
 articular/muscular manifestations). Similar stratification 
was performed for the presence of antinuclear antibo-
dies. For the analysis of CT and MRI findings the following 
classification was employed: the presence and intensity 
of cortical and cortico-subsortical atrophy, as well as the 
presence of focal lesions was assessed (no focal lesions, 
single focal lesion, 2–5 focal lesions, >5 focal lesions, con-
fluent lesions). CT and MR images were analyzed indepen-
dently. The results are presented as percentage and mean, 
and confidence interval was 95%. Data analysis included 
mean values. Significant differences between the sub-
sets of patients were analyzed using the nonparametric 
Mann-Whitney U test. Correlation coefficients between 
chosen clinical features of the disease were determined by 
Spearman’s correlation test. Probability values <0.05 were 
considered significant. 
Results
All patients enrolled into the study exhibited neuropsy-
chiatric symptoms, among which the most common were 
depression, TIA, headache, vertigo, organic brain damage 
syndrome and hypo-/dysmnesia. 
Changes in MRI and CT examinations were detected in 14 
(54%) and in 13 (50%) patients, respectively. 
Among patients with depression, cortical and subcortical 
atrophy of moderate degree was found in 6 (35%) indivi-
duals. Atrophy of significant degree was detected in one 
individual (6%). Additionally, single focal lesions were found 
in 5 patients (29%) according to MRI and in 2 patients (12%) 
according to CT. Among these patients multiple focal lesions 
were detected in 2 individuals (12%) on MRI and in one 
individual (6%) on CT. Diffuse periventricular white matter 
lesions were revealed in 2 patients by MRI and in 1 patient 
by CT. In patients with depression, more focal lesions were 
detected with MRI (7 individuals, 41%) than with CT (3 indi-
viduals, 18%). 
In 2 patients with organic brain damage syndromes, cortical 
and subcortical atrophy lesions of moderate degree were 
detected in both cases in CT and MRI images. Focal white 
matter lesions were observed on MR images only. 
In the patients with TIA history (4 individuals), cortical 
and subcortical atrophy of moderate degree were present 
in 2 cases (visualized with both techniques). Single focal 
lesions were revealed with both techniques in one patient. 
Multiple focal lesions were found in 1 patient with MRI 
only (CT scan was normal). Additionally, diffuse periven-
tricular white matter hyperintensities were detected with 
both techniques in one patient. 
In the subset of patients with headaches and vertigo, ima-
ging studies revealed no morphological changes. 
There were no significant differences between clinical fea-
tures of brain involvement in both disease subsets, diffu-
se SSc or limited SSc. Imaging techniques revealed similar 
distribution of brain lesions in both subtypes. 
Disease duration correlated with the presence of atrophy 
on CT and MR images (p=0,0001) and with the presence of 
focal lesions, where a very strong correlation (p=0,0001) 
was found for MRI images only. Additionally, a correlation 
between the disease duration and the presence of diffuse 
lesions in CT (p=0,008) and MRI (p=0,007) was recorded. 
Interestingly, the presence of pulmonary manifestations, 
characteristic for SSc also corresponded with abnormal CT 
(p=0.012) and MRI (p=0.001) findings. 
Investigation of antibody profile revealed presence of anti-
nuclear antibodies in 96% SSc patients. There was no signi-
ficant correlation between the presence of antinuclear anti-
bodies (Topo I or ACA) and brain involvement, as assessed 
by either CT or MRI. 
Statistically significant correlation was recorded between 
profound skin sclerosis and the presence of focal lesions on 
CT and MRI (p<0.05). 
Discussion
Vascular abnormalities in skin, subcutaneous tissue and 
internal organs, such as lung, heart, gastro-intestinal tract 
and kidneys are common findings in patients with SSc. 
A major abnormality in this regard are episodic vasospasm 
attacks, contributing to vascular abnormalities by a mecha-
nism of reperfusion injury of endothelium. Several data 
indicate that this phenomenon might also have an effect 
on the central nervous system in SSc. However, neurologic 
involvement in SSc was only infrequently reported. Studies 
showed impaired cerebral blood flow, cases of cerebritis 
and central nervous system vasculitis, as well as neuropsy-
chiatric symptoms [6,7,8,9]. Symptoms, such as headaches, 
vertigo, loss of consciousness, hypo-/dysmnesia, depressi-
ve and organic brain damage syndromes, transient ischae-
mic attacks (TIA) and cerebral infarction with paresis were 
reported in patients with SSc [13]. Lesions visible on CT and 
MRI are the consequence of complex (multifactorial) patho-
genesis leading to vasculopathy and brain damage. 
From a pathological point of view mentioned above white 
matter lesions are the result of WM degeneration, ische-
mic demyelination and reactive gliosis. Although corti-
cal atrophy seems to be a consequence of central nervous 
system vasculopathy
In this study the value of CT and MRI in diagnosis of cen-
tral nervous system involvement in SSc was assessed. Our 
results show that MRI is a more sensitive imaging techni-
que than CT for detecting single focal changes (white mat-
ter hyperintensities). In patients presenting clinical neuro-
psychiatric symptoms, alterations in MRI were detected in 
54% patients whereas CT scan abnormalities were present 
in 50% patients. Most prominent findings were cortical and 
subcortical atrophy. MRI was an especially valuable tool 
for detecting single and multiple focal lesions(white matter 
hyperintensities). MRI technique(T2 ,FLAIR) showed in the 
regard a fourfold higher sensitivity compared to CT. 
Also diffuse periventricular lesions were detected in 2 patients 
by MRI and in only 1 patient by CT. 
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Studies performed in other connective tissue diseases, pre-
dominantly systemic lupus erythematosus, show that disor-
ders of coagulability, especially the presence of antipho-
spholipid antibodies, might promote much more advanced 
cerebral ischaemic changes [19]. This study revealed a 
strong correlation between lung involvement and abnor-
malities in brain CT and MRI scans. It may be suggested 
that brain ischaemic lesions in SSc might be secondary to 
generalized hypoxia resulting from lung fibrosis. One may 
also hypothesize that both, profound lung involvement and 
significant brain abnormalities in SSc might be a general 
manifestation of a more severe disease process. 
This hypothesis might be confirmed by our finding that 
there is a significant relationship between profound skin 
sclerosis and the presence of focal brain lesions on CT and 
MRI in SSc patients.
In conclusion, our data indicate that brain abnormali-
ties are common in patients with severe SSc. MRI and CT 
are equally effective in detecting cortical and subcortical 
atrophy in SSc, however MRI shows significantly higher 
than CT sensitivity in detection of focal white matter brain 
lesions in these patients.
Figure 1 a, b.  61 year-old woman with 14 year history of SSc and TIAs (episodic left haemiparesis and dysphasia). MRI, FSE, T2-weighted and 
FLAIR images: mild atrophy with ventricular enlargement, vasogenic scar in right parietotemporal region, multiple focal lesions in 
periventricular, deep and subcortical location.
Rycina 1 a, b.  61-letnia kobieta z 14-letnim wywiadem i TIA (incydenty niedowładu lewostronnego i zaburzeń mowy). MRI, FSE, obrazy T2-zależne, 
sekwencja FLAIR: zanik korowo-podkorowy nieznacznego stopnia z poszerzeniem układu komorowego, blizna naczyniopochodna 
w prawej okolicy ciemieniowo-skroniowej, liczne ogniskowe zmiany okołokomorowe w strukturach głębokich oraz zlokalizowane 
podkorowo.
Figure 2.  41 year-old woman with 15 year history of SSc and 2 year 
history of depression and vertigo. MRI, FSE, FLAIR image: 
moderate atrophy with mild ventricular enlargement and sulci 
widening, multiple white matter focal lesions and areas of 
myelin damage with subsequent gliosis.
Rycina 2.  41-letnia chora z 10-letnim wywiadem twardziny układowej 
oraz depresją i zawrotami głowy od 2 lat. MRI, FSE, 
sekwencja FLAIR: zanik korowo-podkorowy miernego 
stopnia z nieznacznym poszerzeniem układu komorowego 
oraz bruzd. Liczne ogniska w istocie białej mózgu, obszary 
uszkodzenia mieliny i następowej glikozy.
A B
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Figure 3 a, b.  53 year old woman with 16 year history of SSc and 3 year history of depression and severe episodes of headache; no focal deficits 
on neurologic examination; CT revealed mild/moderate atrophy:MRI, FSE, T2-weighted and FLAIR images: mild/moderate atrophy, 
multiple confluent focal lesions of leukoaraiosis type.
Rycina 3 a, b.  53-letnia kobieta z 16-letnim wywiadem twardziny układowej. Od 3 lat depresja i silne bóle głowy, w badaniu neurologicznym bez cech 
ogniskowego uszkodzenia OUN. W badaniu TK nieznacznego/miernego zanik korowo-podkorowy. MRI, obrazy FSE, T2-zależne, 
sekwencja FLAIR: zanik korowo-podkorowy nieznacznego/miernego i liczne zlewające się zmiany okołokomorowe o typie leukoaraiosis.
Figure 4 a, b, c.  58 year old man with 23 year history of SSc, complaining 
on memory loss and concentration deficits with detorio-
ration of daily functions from 3 years; periodical severe 
headache and vertigo; episode of right sided haemipare -
sis 4 years ago: MRI, FSE, T2-weighted and FLAIR 
images: multiple, partialy confluent focal lesions localized 
in periventricular and subcortical white matter as well as in 
deep structures of both haemispheres; moderate atrophy 
predominantly in frontal and frontotemporal regions.
Rycina 4 a, b, c.  58-letni mężczyzna z 23-letnim wywiadem twardziny 
układowej. Od 3 lat zgłasza osłabienie pamięci, zaburze-
nia koncentracji i coraz gorsze funkcjonowanie w życiu 
codzien nym. Okresowo silne bóle i zawroty głowy, przed
4 laty epizod niedowładu prawostronnego. MRI, FSE, 
obrazy T2-zależne, sekwencja FLAIR: liczne ogniska 
zlokalizowane w podkorowej istocie białej, około komo-
rowo i w strukturach głębokich półkul mózgu, częściowo
zlewające się ze sobą. Zanik umiarkowanego stop nia,
zwłaszcza w okolicach czołowych i czołowo-skroniowych.
A B
A B
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